跳至主要内容
临床试验/NCT04750967
NCT04750967已完成不适用

Comparison of Amitriptyline and Nerve Blocks (GON and SON) in Patients With Migraine

Dr. Lutfi Kirdar Kartal Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2021年4月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
57
试验地点
1
主要终点
Number of Participants with 50% Reduction of Headache Frequency

研究概览

简要总结

Comparison of efficacy and safety of amitriptyline and nerve blocks

详细描述

This study aims to compare the efficacy and safety of amitriptyline and nerve blocks (greater occipital nerve and supraorbital nerve)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with migraine according to ICHD-3

排除标准

  • Being over 50 years or under 18 years
  • Malignancy and other systemic diseases

研究组 & 干预措施

Active

Experimental

Greater occipital nerve and supraorbital nerve block with 1% lidocaine once a week for first four weeks then once a month for 5 months

干预措施: Lidocaine 1% Injectable Solution (Drug)

Control

Active Comparator

Amitriptyline 25 mg daily for 6 months

干预措施: Amitriptyline (Drug)

结局指标

主要结局

Number of Participants with 50% Reduction of Headache Frequency

时间窗: 6 months

Monthly headache frequency will be followed

次要结局

  • Side effects(6 months)

研究者

发起方
Dr. Lutfi Kirdar Kartal Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Cem Bölük

Principal Investigator

Dr. Lutfi Kirdar Kartal Training and Research Hospital

研究点 (1)

Loading locations...

相似试验